🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate in a 3 +3 design, the safety of ...
Status
Completed
Location
University of California, Moores Cancer Center
Start Date
2015-12
Trial ID
NCT02643550
Treatments Being Tested
This is a phase 2 open-label two cohort study of durvalumab plus monalizuma...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2025-02-24
Trial ID
NCT06503614
Treatments Being Tested
The study is intended to assess the safety and efficacy of perioperative tr...
Status
Recruiting
Location
Research Site
Start Date
2022-04-14
Trial ID
NCT05061550
This is a Phase III, randomised, double-blind, multicentre, international s...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-02-07
Trial ID
NCT05221840
Treatments Being Tested
Combination study of monalizumab (IPH2201) with Ibrutinib in relapsed, refr...
Status
Terminated
Location
The Ohio State University Wexner Medical Center
Start Date
2015-11-09
Trial ID
NCT02557516
Treatments Being Tested
ARTemIS-Eso is a phase I-II, three-level, open-label trial with a dose-expa...
Status
Withdrawn
Location
Institut Jules Bordet
Start Date
2017-07-20
Trial ID
NCT03307941
Treatments Being Tested
Study D9108C00002 (NeoCOAST) is a platform study assessing the effectivenes...
Status
Completed
Location
Research Site
Start Date
2019-03-08
Trial ID
NCT03794544
Treatments Being Tested
MSI is a molecular indicator of defective DNA mismatch repair (dMMR). The M...
Status
Withdrawn
Location
Department of medical oncology - Saint-Antoine Hospital
Start Date
2023-12
Trial ID
NCT06152523
Treatments Being Tested
This is a randomized trial evaluating the efficacy and safety of sequential...
Status
Not Yet Recruiting
Location
Montefiore Medical Center
Start Date
2026-09
Trial ID
NCT07146230
Treatments Being Tested
This study will determine the Maximal Tolerated Dose if any and the recomme...
Status
Unknown
Location
Institut Paoli Calmettes
Start Date
2016-11-28
Trial ID
NCT02921685
Treatments Being Tested